A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Talazoparib
Related studies linked through entity extraction aliases.
Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial
- Status
- RECRUITING
- Phase
- PHASE2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2